Montana legislation · 2025 Regular Session
Montana SB422: Generally revise laws relating to insurance coverage relating to cancer
Status: Chaptered, July 14, 2025
What the bill says
An act providing requirements for health insurance coverage relating to advanced or metastatic cancer; prohibiting insurers from requiring certain acts from the insured related to prescription drugs and advanced or metastatic cancer; and amending sections 2-18-704, 33-31-111, and 33-35-306, mca.
From the engrossed text:
AN ACT PROVIDING REQUIREMENTS FOR HEALTH INSURANCE COVERAGE RELATING TO ADVANCED OR METASTATIC CANCER; PROHIBITING INSURERS FROM REQUIRING CERTAIN ACTS FROM THE INSURED RELATED TO PRESCRIPTION DRUGS AND ADVANCED OR METASTATIC CANCER; AND AMENDING SECTIONS 2-18-704, 33-31-111, AND 33-35-306, MCA. Section 1. Coverage for advanced or metastatic cancer. (1) Insurers who sell health insurance coverage available through the group market or individual market in this state and who provide coverage for advanced or metastatic cancer may not, before the health insurance provides coverage of a prescription drug approved by the United States food and drug administration and as long as prescribing is consistent with national comprehensive cancer network guidelines, require that the or (b) prove a history of failure of a different drug. (2) This section applies only to a drug whose use (b) supported by peer-reviewed, evidence-based literature; and (c) approved by the United States Food and Drug Administration. (3) For the purposes of this section, the following definitions apply: (a) "Advanced or metastatic cancer" means cancer that has spread from the primary or original site of the cancer to nearby tissues, lymph nodes, or other areas of the body or that has progressed beyond early stages and is considered terminal cancer. (b) "Terminal cancer" means cancer that cannot be cured with treatment and is expected to lead to …
Sponsors
- Boldman, Ellie (D, 47) · primary sponsor
Latest actions
- : (S) Veto Override
- : (S) Veto Override Vote in Progress
- : (S) Vetoed by Governor
- : (S) Transmitted to Governor
- : (H) Signed by Speaker
- : (S) Signed by President
- : (S) Returned from Enrolling
- : (S) Sent to Enrolling
- : (S) 3rd Reading House Amendments
- : (S) Scheduled for 3rd Reading
Votes
- Do Pass (April 17, 2025): 37 yea, 13 nay, passed
- Do Pass (April 16, 2025): 39 yea, 11 nay, passed
- Do Concur (April 11, 2025): 64 yea, 35 nay, passed
- Do Concur (April 11, 2025): 60 yea, 38 nay, passed
- Do Pass (March 5, 2025): 32 yea, 17 nay, passed
- Do Pass As Amended (March 4, 2025): 36 yea, 14 nay, passed
Subjects: Insurance, Health Care Services
Common questions
- What is SB422?
- SB422 is a bill in the Montana Legislature (2025 Regular Session): Generally revise laws relating to insurance coverage relating to cancer.
- What does SB422 do?
- In its own words: An act providing requirements for health insurance coverage relating to advanced or metastatic cancer; prohibiting insurers from requiring certain acts from the insured related to prescription drugs and advanced or metastatic cancer; and amending sections 2-18-704, 33-31-111, and 33-35-306, mca.
- What is the status of SB422?
- Chaptered as of July 14, 2025. Latest action: (S) Veto Override (July 14, 2025).
- Who sponsored SB422?
- Boldman, Ellie (D, 47).
- Where is the official record for SB422?
- On the Montana Legislature website: https://bills.legmt.gov/#/laws/bill/2/LC1934
Source: official Montana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.